NCT07793682

Brief Summary

Cognitive impairment and reduced quality of life are frequent consequences of ischemic stroke, and they also affect the patient's family, who often assume a caregiving role without preparation. Most rehabilitation trials begin three to four months after the acute event, and evidence about earlier intervention is scarce. This randomized clinical trial evaluates two independent interventions initiated 20 days after hospital admission: a structured computerized neuropsychological rehabilitation program for the patient, and a psychoeducational program for the main caregiver. A 2×2 factorial design allows the main effect of each intervention to be estimated within a single sample, as well as their potential interaction. The primary outcome is health-related quality of life at 3 months post-stroke, measured with the CAVIDACE scale and reported by the reference family member. Secondary outcomes include cognitive performance, functional status, mood and caregiver burden. Molecular biomarkers and structural neuroimaging variables are examined as exploratory prognostic factors.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Nov 2025Mar 2027

Study Start

First participant enrolled

November 19, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2027

Last Updated

August 28, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

August 26, 2026

Last Update Submit

August 26, 2026

Conditions

Keywords

stroke rehabilitationneuropsychological rehabilitationpsychoeducationcaregiverfactorial designacute phase

Outcome Measures

Primary Outcomes (1)

  • Health-related quality of life (CAVIDACE total direct score)

    Total direct score of the CAVIDACE scale (Quality of Life in Acquired Brain Injury), completed by the reference family member. Score range 0 to 192; higher scores indicate better quality of life. Analysed by ANCOVA adjusting for the baseline value at day 20 and for the randomization stratum.

    3 months post-stroke (day 90 ± 14 days)

Secondary Outcomes (8)

  • Global neuropsychological composite score

    3 months post-stroke

  • Modified Rankin Scale

    3 months post-stroke

  • Barthel Index

    3 months post-stroke

  • Lawton IADL Scale

    3 months post-stroke

  • Caregiver burden (Zarit)

    3 months post-stroke

  • +3 more secondary outcomes

Other Outcomes (2)

  • Biomarks (BDNF, GFAP, IL-6, CRP, S100B)

    3 months post-stroke

  • Neuroimaging

    3 months post-stroke

Study Arms (4)

Group 1: Control

ACTIVE COMPARATOR
Other: Non-specific recreational cognitive activitiesOther: Written information leaflet

Group 2: Neuropsychological rehabilitation

EXPERIMENTAL
Behavioral: Computerized neuropsychological rehabilitationOther: Written information leaflet

Group 3: Family psychoeducation

EXPERIMENTAL
Behavioral: Family psychoeducational programOther: Non-specific recreational cognitive activities

Group 4: Combined intervention

EXPERIMENTAL
Behavioral: Computerized neuropsychological rehabilitationBehavioral: Family psychoeducational program

Interventions

Structured computerized cognitive training program (Guttmann NeuroPersonalTrainer). 24 sessions of 45 minutes, twice weekly over 12 weeks, starting after randomization at day 20 post-admission.

Group 2: Neuropsychological rehabilitationGroup 4: Combined intervention

Six individual 45-minute sessions delivered fortnightly by videoconference to the main caregiver, covering stroke information, the family role in recovery, emotional management, behavioral difficulties, cognitive therapy techniques and behavioral activation.

Group 3: Family psychoeducationGroup 4: Combined intervention

Simple recreational digital activities without adaptive difficulty, performance feedback or structured progression, matched in duration and frequency to the experimental program.

Group 1: ControlGroup 3: Family psychoeducation

Informational leaflet on stroke, its consequences and available community resources, provided at hospital discharge.

Group 1: ControlGroup 2: Neuropsychological rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First-ever ischemic stroke (transient ischemic attack excluded)
  • Age 18 years or older
  • Prior functional independence (modified Rankin Scale ≤ 1)
  • Diagnostic criteria for ischemic stroke (TACI, PACI, LACI, POCI)
  • Capacity to provide informed consent, or availability of a legal representative

You may not qualify if:

  • Previous neurological or psychiatric disease associated with cognitive impairment
  • Severe systemic disease
  • Life expectancy under one year
  • Severe stroke (NIHSS score above 19 at admission)
  • Alcohol or substance abuse (tobacco excluded)
  • Clinically relevant aphasia preventing comprehension of test instructions Sensory impairment preventing neuropsychological assessment
  • Functional illiteracy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia

Manresa, Barcelona, 08243, Spain

Location

MeSH Terms

Conditions

Ischemic StrokeCognitive DysfunctionCaregiver Burden

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesCognition DisordersNeurocognitive DisordersMental DisordersStress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Jordi Sanchez Monteagudo, Doctorate Student

    Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the nature of the interventions, participants, their family members and the professionals delivering the interventions cannot be blinded. Outcome assessors, laboratory personnel, the neuroimaging reader and the statistician are blinded to group allocation.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Neuropsychologist, Principal Investigator

Study Record Dates

First Submitted

August 26, 2026

First Posted

August 28, 2026

Study Start

November 19, 2025

Primary Completion (Estimated)

November 25, 2026

Study Completion (Estimated)

March 20, 2027

Last Updated

August 28, 2026

Record last verified: 2026-08

Locations